Cargando…

Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with Concurrent Clostridium Difficile Infection

Pembrolizumab is a programmed death receptor-1 (PD-1) inhibitor that has been approved for treatment of a wide variety of malignancies. Immune-mediated colitis is a known but uncommon adverse effect of pembrolizumab. Symptoms of immune-mediated colitis can be similar to those of many other gastroint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Cheng, Klionsky, Yael, Treasure, Michelle E., Bruno, Debora S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477466/ https://www.ncbi.nlm.nih.gov/pubmed/31043955 http://dx.doi.org/10.1159/000497155

Ejemplares similares

Blastocystis sp. Infection Mimicking Clostridium Difficile Colitis
por: Gil, Gaby S., et al.
Publicado: (2016)

Non-clostridium difficile induced pseudomembranous colitis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Toxic megacolon in Clostridium difficile colitis
por: Fukui, Sayato, et al.
Publicado: (2023)

Clinical Predictors of Fulminant Colitis in Patients with Clostridium difficile Infection
por: Girotra, Mohit, et al.
Publicado: (2012)

Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Bench-to-bedside review: Clostridium difficile colitis
por: Gould, Carolyn V, et al.
Publicado: (2008)

Pseudomembranous Colitis: Not Always Caused by Clostridium difficile
por: Tang, Derek M., et al.
Publicado: (2014)

Hemolytic uremic syndrome and Clostridium difficile colitis
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2012)

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
por: Loftus, Edward V, et al.
Publicado: (2022)

Bezlotoxumab Therapy for Recurrent Clostridium difficile Infection in an Ulcerative Colitis Patient
por: Fein, Aaron, et al.
Publicado: (2022)

Clostridium difficile induced colitis occurring during cefotaxime therapy.
por: Green, S. T., et al.
Publicado: (1985)

The Risk Factors of Clostridium difficile Colitis in Colorectal Surgery
por: Yoo, Seung Jin
Publicado: (2010)

Clostridium difficile colitis – a serious current problem
por: Dumitru, Irina Magdalena, et al.
Publicado: (2013)

Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis
por: Shah, Nihar, et al.
Publicado: (2014)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

Acute Appendicitis: An Extracolonic Manifestation of Clostridium difficile Colitis
por: Ridha, Ali, et al.
Publicado: (2017)

Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature
por: Vuillamy, Chloé, et al.
Publicado: (2023)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Clostridium difficile Infection
por: Magdesian, K. Gary
Publicado: (2003)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

A case of reactive arthritis due to Clostridium difficile colitis
por: Essenmacher, Alex C., et al.
Publicado: (2016)

Epidemiological and clinical considerations on Clostridium difficile colitis in Braşov County
por: Cocuz, Maria Elena, et al.
Publicado: (2014)

Treatment of recurrent Clostridium difficile colitis: a narrative review
por: Hopkins, Roy J, et al.
Publicado: (2018)

Clostridium difficile colitis and zoonotic origins—a narrative review
por: Brown, Alexander W W, et al.
Publicado: (2018)

Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
por: Mehershahi, Shehriyar, et al.
Publicado: (2021)

Piperacillin/tazobactam/vancomycin: Clostridium difficile colitis: case report
Publicado: (2021)

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
por: Carlucci, Christian, et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Clostridium difficile Infection in a Very Young Infant with Pseudomembranous Colitis Noted on Endoscopy
por: Tibesar, Eric
Publicado: (2020)

Amoxicillin/clavulanic-acid: Clostridium difficile infection in the form of pseudomembranous colitis: case report
Publicado: (2022)

Clostridium difficile infections in China()
por: Jin, Ke, et al.
Publicado: (2010)

Clostridium difficile infection: review
por: Czepiel, Jacek, et al.
Publicado: (2019)

Nicotine Inhibits Clostridium difficile Toxin A-Induced Colitis but Not Ileitis in Rats
por: Vigna, Steven R.
Publicado: (2016)

Pembrolizumab: Autoimmune haemolytic anaemia and immune-mediated colitis: case report
Publicado: (2021)

Risk factors for the development of Clostridium difficile colitis in a surgical ward
por: Kim, Min Jeong, et al.
Publicado: (2012)

A Case of Concomitant Emphysematous Cystitis and Clostridium difficile Colitis with Pneumoperitoneum
por: Tariq, Tooba, et al.
Publicado: (2018)

Clostridium difficile Enteritis after Total Abdominal Colectomy for Ulcerative Colitis
por: Nasser, Hassan, et al.
Publicado: (2019)

Clostridium difficile isolated from faecal samples in patients with ulcerative colitis
por: Shoaei, Parisa, et al.
Publicado: (2019)

Atypical Hemolytic Uremic Syndrome in the Setting of Acute Clostridium difficile Colitis
por: Wadehra, Anshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tbdu5rqksu0l3jg979jjl9b0fd